BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15686160)

  • 1. Molecular virology in chronic hepatitis B: genotypes.
    Wong GL; Chan HL
    Hosp Med; 2005 Jan; 66(1):13-6. PubMed ID: 15686160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.
    Liu CJ; Kao JH
    Semin Liver Dis; 2013 May; 33(2):97-102. PubMed ID: 23749665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
    Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
    Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia.
    Milosevic I; Delic D; Lazarevic I; Pavlovic IP; Korac M; Bojovic K; Jevtovic D
    J Clin Virol; 2013 Sep; 58(1):54-8. PubMed ID: 23838671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
    Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
    Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the various mutations in viral core promoter region to different stages of hepatitis B, ranging of asymptomatic carrier state to hepatocellular carcinoma.
    Yin J; Xie J; Liu S; Zhang H; Han L; Lu W; Shen Q; Xu G; Dong H; Shen J; Zhang J; Han J; Wang L; Liu Y; Wang F; Zhao J; Zhang Q; Ni W; Wang H; Cao G
    Am J Gastroenterol; 2011 Jan; 106(1):81-92. PubMed ID: 20959817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Viral factors and outcomes of chronic HBV infection.
    Huang Y; Lok AS
    Am J Gastroenterol; 2011 Jan; 106(1):93-5. PubMed ID: 21212756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.
    Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F
    Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development.
    Hu L; Zhai X; Liu J; Chu M; Pan S; Jiang J; Zhang Y; Wang H; Chen J; Shen H; Hu Z
    Hepatology; 2012 May; 55(5):1426-31. PubMed ID: 22105689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical implications of hepatitis B virus genotype: Recent advances.
    Lin CL; Kao JH
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():123-30. PubMed ID: 21199523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular virology of hepatitis B virus, sub-genotype C4 in northern Australian Indigenous populations.
    Littlejohn M; Davies J; Yuen L; Edwards R; Sozzi T; Jackson K; Cowie B; Tong S; Davis J; Locarnini S
    J Med Virol; 2014 Apr; 86(4):695-706. PubMed ID: 24497078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus genotyping: current methods and clinical implications.
    Guirgis BS; Abbas RO; Azzazy HM
    Int J Infect Dis; 2010 Nov; 14(11):e941-53. PubMed ID: 20674432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B.
    Kim BK; Revill PA; Ahn SH
    Antivir Ther; 2011; 16(8):1169-86. PubMed ID: 22155900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1846 and A/G1913 are associated with acute on chronic liver failure in patients infected with hepatitis B virus genotypes B and C.
    Yan T; Li K; Li F; Su H; Mu J; Tong S; Patel M; Xia J; Wands JR; Wang H
    J Med Virol; 2011 Jun; 83(6):996-1004. PubMed ID: 21503912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stemming the tide of hepatitis B virus related hepatocellular carcinoma?
    Thomas MB; Davila M; Abbruzzese JL
    J Clin Oncol; 2008 Jan; 26(2):172-4. PubMed ID: 18182657
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic implications of hepatitis B virus genotypes.
    Liu CJ; Kao JH; Chen DS
    Liver Int; 2005 Dec; 25(6):1097-107. PubMed ID: 16343058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of chronic hepatitis B: extending the REVEAL study.
    Cooksley WG
    Liver Int; 2010 Sep; 30(8):1085-6. PubMed ID: 20492519
    [No Abstract]   [Full Text] [Related]  

  • 18. HBV genotype and clinical outcome of chronic hepatitis B: facts and puzzles.
    Tseng TC; Kao JH
    Gastroenterology; 2008 Apr; 134(4):1272-3; author reply 1273. PubMed ID: 18395116
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of hepatocellular carcinoma.
    Wands JR
    N Engl J Med; 2004 Oct; 351(15):1567-70. PubMed ID: 15470221
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.